semaglutide anesthesia guidelines Updated guidance for patients using GLP-1/GIP receptor agonists

Perioperative Considerations for Patients on Semaglutide | Current Anesthesiology Reports

24.61

★★★★☆4.8 (126)

Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

23.58

★★★★★4.9 (98)

🔴🚨 Updated perioperative guidelines for patients on GLP-1s, GIP/GLP-1s, and SGLT2 inhibitors 🚨⤵️ 🔹With millions now taking these agents for obesity, diabetes, CV, and renal protection, surgery teams are seeing these meds

26.85

★★★★★5.0 (157)

How should GLP-1 receptor agonists be managed in the perioperative period?

23.30

★★★★★4.7 (84)

Concerns have been raised about whether the delayed gastric emptying caused by GLP-1–based medications might jeopardize patient safety during procedures that require sedation. A randomized trial takes a closer look

24.08

★★★★★4.9 (203)

Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice - Milder - 2024 - Anaesthesia

23.86

★★★★★5.0 (176)

🇬🇧 Perioperative Management of New Popular Agents: GLP-1 Agonists (GLP-1 RA: semaglutide, tirzepatide) These drugs delay gastric emptying → patients may have a “full stomach” despite fasting This increases risk of regurgitation

24.79

★★★★★4.8 (132)